Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.

MLA

Zhenjiang, Liu, et al. “Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.” EBioMedicine, vol. 33, July 2018, pp. 49–56. EBSCOhost, https://doi.org/10.1016/j.ebiom.2018.06.014.

APA

Zhenjiang, L., Rao, M., Luo, X., Valentini, D., von Landenberg, A., Meng, Q., Sinclair, G., Hoffmann, N., Karbach, J., Altmannsberger, H.-M., Jäger, E., Peredo, I. H., Dodoo, E., & Maeurer, M. (2018). Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme. EBioMedicine, 33, 49–56. https://doi.org/10.1016/j.ebiom.2018.06.014

Chicago

Zhenjiang, Liu, Martin Rao, Xiaohua Luo, Davide Valentini, Anna von Landenberg, Qingda Meng, Georges Sinclair, et al. 2018. “Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.” EBioMedicine 33 (July): 49–56. doi:10.1016/j.ebiom.2018.06.014.